Skip to main content

Table 2 Anticipated estimates for DR-TB-related incidence, prevalence and mortality changes over time in the baseline (no-bedaquiline scenario)

From: Long-term impact of the adoption of bedaquiline-containing regimens on the burden of drug-resistant tuberculosis in China

YearDR-TB epidemiological parameter (all figures in thousands)
IncidencePrevalenceMortality
202069.9218.930.6
203080.7240.034.9
204091.0260.738.6